glp-1 colon cancer Receptor Agonists Reduce Colorectal Risk in IBD Populations Frontiers | Glucagon-like peptide-1 receptor

Many patients experience slower progress after nine to twelve months of therapy, although timing varies depending on adherence, dose optimization, and underlying metabolic conditions

Peak blood concentration occurred between 8 and 72 hours post-injection regardless of location, and the total amount of medication entering the bloodstream was equivalent

In The Atlantic , Sarah Zhang called them powerful modulators of appetite, acting not only through the gut but on the brain itself

Saxenda: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, upset stomach, fatigue, dizziness, abdominal pain, increased lipase (a digestive enzyme), upper abdominal pain, fever, and gastroenteritis (inflammation of the stomach and intestines)